日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study

在重症肌无力患者中,通过手动推注和输注泵方法自我给药罗扎诺利珠单抗:一项随机、3期、开放标签、交叉研究

Bril, Vera; Antozzi, Carlo; Berkowicz, Tomasz; Drużdż, Artur; Gandhi Mehta, Rachana K; Mahuwala, Zabeen K; Zschüntzsch, Jana; Boehnlein, Marion; Kerbusch, Virginie; Lavrov, Andreea; Morris, Mark; Singh, Puneet; Leite, M Isabel

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

终末期肾病透析患者克拉扎珠单抗的群体药代动力学和药代动力学-药效学分析

Muthukrishnan, Venkateswari Y; Kerbusch, Thomas; Strong, Laura E; Kleijn, Huub Jan; Pfister, Marc; Chang, Anna Marie; Acharya, Milin; Nandy, Partha; McCune, Jeannine S

Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open-Label, 1-Sequence, Crossover Studies

罗沙司他(Roxadustat)对健康受试者体内辛伐他汀、瑞舒伐他汀和阿托伐他汀药代动力学的影响:来自3项I期开放标签、单序列交叉研究的结果

Groenendaal-van de Meent, Dorien; den Adel, Martin; Kerbusch, Virginie; van Dijk, Jan; Shibata, Tomohisa; Kato, Kota; Schaddelee, Marloes

Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

肾功能和透析对口服缺氧诱导因子脯氨酰羟化酶抑制剂罗沙司他药代动力学和药效学的影响

Groenendaal-van de Meent, Dorien; Kerbusch, Virginie; Kaspera, Rudiger; Barroso-Fernandez, Begona; Galletti, Piergiorgio; Klein, Gernot K; den Adel, Martin

Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab

评估免疫原性对tildrakizumab的药代动力学、疗效和安全性的影响

Kimball, A B; Kerbusch, T; van Aarle, F; Kulkarni, P; Li, Q; Blauvelt, A; Papp, K A; Reich, K; Montgomery, D

Artificial Intelligence and Machine Learning Applied at the Point of Care

人工智能和机器学习在护理点的应用

Angehrn, Zuzanna; Haldna, Liina; Zandvliet, Anthe S; Gil Berglund, Eva; Zeeuw, Joost; Amzal, Billy; Cheung, S Y Amy; Polasek, Thomas M; Pfister, Marc; Kerbusch, Thomas; Heckman, Niedre M

Population Pharmacokinetics and Pharmacodynamics of Bezlotoxumab in Adults with Primary and Recurrent Clostridium difficile Infection

贝洛妥珠单抗在原发性和复发性艰难梭菌感染成人患者中的群体药代动力学和药效学研究

Yee, Ka Lai; Kleijn, Huub Jan; Kerbusch, Thomas; Matthews, Randolph P; Dorr, Mary Beth; Garey, Kevin W; Wrishko, Rebecca E

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

母婴拉替拉韦群体药代动力学模型:对新生儿初始给药的启示

Lommerse, Jos; Clarke, Diana; Kerbusch, Thomas; Merdjan, Henri; Witjes, Han; Teppler, Hedy; Mirochnick, Mark; Acosta, Edward P; Wenning, Larissa; Nachman, Sharon; Chain, Anne

Anisotropic metal growth on phospholipid nanodiscs via lipid bilayer expansion

通过脂质双层扩张在磷脂纳米盘上实现各向异性金属生长

Oertel, Jana; Keller, Adrian; Prinz, Julia; Schreiber, Benjamin; Hübner, René; Kerbusch, Jochen; Bald, Ilko; Fahmy, Karim

Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid

血浆和肺上皮衬液中亚胺培南的群体药代动力学模型

van Hasselt, J G Coen; Rizk, Matthew L; Lala, Mallika; Chavez-Eng, Cynthia; Visser, Sandra A G; Kerbusch, Thomas; Danhof, Meindert; Rao, Gauri; van der Graaf, Piet H